MorphoSys AG Form SC TO-T/Amended Shows Novartis BidCo AG Bought 2,023,370 Shares Of Common Stock Or About A 5.36% Stake; Highest Price Paid Was €67.95 Per Share
MorphoSys AG Form SC TO-T/Amended Shows Novartis BidCo AG Bought 2,023,370 Shares Of Common Stock Or About A 5.36% Stake; Highest Price Paid Was €67.95 Per Share
On 11 April 2024, Novartis BidCo, Basel, Switzerland, ("Bidder") has published the offer document regarding its takeover offer (cash offer) to the shareholders of MorphoSys AG, Planegg, Germany ("MorphoSys") for the acquisition of all no-par value bearer shares (ISIN DE0006632003) ("MorphoSys Shares") including all no-par value bearer shares represented by American Depositary Shares (ISIN US6177602025) ("MorphoSys ADS") in MorphoSys against payment of a cash consideration in the amount of EUR 68.00 per MorphoSys Share. The acceptance period of the offer will expire on 13 May 2024, 24:00 hours (local time Frankfurt am Main, Germany) and 18:00 hours (local time New York, United States of America), unless it is extended pursuant to the applicable rules under the WpÜG.
As of 12 April 2024 ("Reference Date"), i.e. after the publication of the offer document and prior to the publication pursuant to section 23 para. 1 sentence 1 no. 2 WpÜG, the Bidder acquired 2,023,370 MorphoSys Shares on the stock exchange. The highest price paid was EUR 67.95 per MorphoSys Share. The transfer of the 2,023,370 MorphoSys Shares to the Bidder is expected to take place within the next few days.
The aggregate number of MorphoSys Shares for which purchase agreements were entered into on the Reference Date represents approx. 5.36 % of all MorphoSys Shares in existence on the Reference Date and approx. 5.37 % of all MorphoSys Shares in existence, other than treasury shares held by MorphoSys, on the Reference Date.
On 11 April 2024, Novartis BidCo, Basel, Switzerland, ("Bidder") has published the offer document regarding its takeover offer (cash offer) to the shareholders of MorphoSys AG, Planegg, Germany ("MorphoSys") for the acquisition of all no-par value bearer shares (ISIN DE0006632003) ("MorphoSys Shares") including all no-par value bearer shares represented by American Depositary Shares (ISIN US6177602025) ("MorphoSys ADS") in MorphoSys against payment of a cash consideration in the amount of EUR 68.00 per MorphoSys Share. The acceptance period of the offer will expire on 13 May 2024, 24:00 hours (local time Frankfurt am Main, Germany) and 18:00 hours (local time New York, United States of America), unless it is extended pursuant to the applicable rules under the WpÜG.
2024年4月11日，位於瑞士巴塞爾的諾華BidCo（“投標人”）發佈了關於其向德國普拉內格MorphoSys股份公司（“MorphoSys”）股東提出的收購要約（現金要約），以收購所有無面值不記名股票（ISIN DE0006632003）（“MorphoSys”）（“MorphoSys”）（“MorphoSys”）的收購要約（“MorphoSys”） 股票“）包括以MorphoSys的美國存托股票（ISIN US6177602025）（“MorphoSys ADS”）爲代表的所有無面值不記名股票，以支付每股MorphoSys股票68.00歐元的現金對價。該優惠的接受期將於 2024 年 5 月 13 日 24:00（當地時間德國美因河畔法蘭克福）和 18:00（當地時間美利堅合衆國紐約）到期，除非根據WPUG的適用規則延長。
As of 12 April 2024 ("Reference Date"), i.e. after the publication of the offer document and prior to the publication pursuant to section 23 para. 1 sentence 1 no. 2 WpÜG, the Bidder acquired 2,023,370 MorphoSys Shares on the stock exchange. The highest price paid was EUR 67.95 per MorphoSys Share. The transfer of the 2,023,370 MorphoSys Shares to the Bidder is expected to take place within the next few days.
截至2024年4月12日（“參考日期”），即在要約文件發佈之後，以及根據WPUg第23條第1款第1句發佈之前，投標人在證券交易所收購了2,023,370股MorphoSys股票。支付的最高價格爲每股MorphoSys股票67.95歐元。預計將在未來幾天內向投標人轉讓2,023,370股MorphoSys股票。
The aggregate number of MorphoSys Shares for which purchase agreements were entered into on the Reference Date represents approx. 5.36 % of all MorphoSys Shares in existence on the Reference Date and approx. 5.37 % of all MorphoSys Shares in existence, other than treasury shares held by MorphoSys, on the Reference Date.
在基準日簽訂購買協議的MorphoSys股票總數約佔基準日所有MorphoSys股票的5.36％，約佔基準日除MorphoSys持有的庫存股以外的所有MorphoSys現有股票的5.37％。
譯文內容由第三人軟體翻譯。
風險及免責聲明
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能，分享給你的好友吧